A SPECIALIST laboratory at the University of Glasgow has developed a new cancer test for research and clinical trials that could ultimately change the way cancer medicine is delivered.
The Glasgow Cancer Tests are a suite of affordable solid tumour and blood cancer tests developed by the Glasgow Precision Oncology Laboratory (GPOL).
They are designed to be used in routine healthcare to enable doctors to offer the latest treatments and trials to cancer patients. These tests will also help scientists discover what makes cancer resistant to chemotherapy drugs, as well as provide data that will aid the development of new treatments. The tests are currently being evaluated by NHS labs in Scotland and England.
The tests are also being used in the University of Glasgow-led Precision-Panc clinical trials programme for patients with pancreatic cancer.
Professor Andrew Biankin, regius chair of surgery at the University of Glasgow and director of the GPOL, said: “The Glasgow Cancer Tests were created so that ultimately every patient with cancer could have access to the latest treatments and clinical trials.
“Our team of inventors, including Susie Cooke, Philip Beer and David Chang, have dedicated the last five years of their lives to creating the Glasgow Cancer Tests.”
The tests can be used for any cancer and will provide into what is driving a patient’s cancer, and therefore which drugs would be best to trial for that patient.
Why are you making commenting on The National only available to subscribers?
We know there are thousands of National readers who want to debate, argue and go back and forth in the comments section of our stories. We’ve got the most informed readers in Scotland, asking each other the big questions about the future of our country.
Unfortunately, though, these important debates are being spoiled by a vocal minority of trolls who aren’t really interested in the issues, try to derail the conversations, register under fake names, and post vile abuse.
So that’s why we’ve decided to make the ability to comment only available to our paying subscribers. That way, all the trolls who post abuse on our website will have to pay if they want to join the debate – and risk a permanent ban from the account that they subscribe with.
The conversation will go back to what it should be about – people who care passionately about the issues, but disagree constructively on what we should do about them. Let’s get that debate started!
Callum Baird, Editor of The National
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules here